CI Relative Valuation
CI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CI is overvalued; if below, it's undervalued.
Historical Valuation
Cigna Group (CI) is now in the Undervalued zone, suggesting that its current forward PE ratio of 10.35 is considered Undervalued compared with the five-year average of 10.92. The fair price of Cigna Group (CI) is between 359.23 to 410.61 according to relative valuation methord. Compared to the current price of 315.99 USD , Cigna Group is Undervalued By 12.04%.
Relative Value
Fair Zone
359.23-410.61
Current Price：315.99
12.04%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
2.15
P/B
Median3y
2.04
Median5y
1.85
7.28
FCF Yield
Median3y
10.21
Median5y
10.08
Competitors Valuation Multiple
The average P/S ratio for CI's competitors is 0.33, providing a benchmark for relative valuation. Cigna Group Corp (CI) exhibits a P/S ratio of 0.32, which is -2.36% above the industry average. Given its robust revenue growth of 14.40%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Cigna Group (CI) currently overvalued or undervalued?
What is Cigna Group (CI) fair value?
How does CI's valuation metrics compare to the industry average?
What is the current P/B ratio for Cigna Group (CI) as of May 24 2025?
What is the current FCF Yield for Cigna Group (CI) as of May 24 2025?
What is the current Forward P/E ratio for Cigna Group (CI) as of May 24 2025?